35 Stocks Moving In Tuesday's Mid-Day Session



  • Cumberland Pharmaceuticals Inc. CPIX shares jumped 105.9% to $4.53. The FDA approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in pre-operative administration.
  • Adagio Therapeutics, Inc. ADGI gained 52.7% to $71.51. Adagio Therapeutics gained more than 86% on Monday after the company said its COVID-19 monoclonal antibody, ADG20, is likely to retain activity against Omicron, as observed in in vitro models with all other variants of concern identified previously.
  • Pioneer Power Solutions, Inc. PPSI shares climbed 33.8% to $10.21 after dipping 27% on Monday.
  • ImmunoGen, Inc. IMGN gained 30.1% to $6.18 in reaction to positive topline data from the SORAYA trial of mirvetuximab soravtansine for ovarian cancer. The trial is evaluating mirvetuximab as monotherapy in patients with folate receptor alpha (FRα)-high platinum-resistant ovarian cancer who have been previously treated with Roche Holdings AG's RHHBY Avastin (bevacizumab).
  • Vir Biotechnology, Inc. VIR jumped 20.8% to $48.90 after HC Wainwright & Co maintained a Buy rating on the stock and raised its price target from $135 to $200.
  • Context Therapeutics Inc. CNTX shares rose 20% to $6.70 after climbing 9% on Monday.
  • Molecular Partners AG MOLN rose 16.6% to $13.86 after the company confirmed retained activity of ensovibep on the positions mutated in emerging omicron variant of SARS-CoV-2 in vitro.
  • ContraFect Corporation CFRX surged 16.4% to $3.75.
  • MEI Pharma, Inc. MEIP gained 16.2% to $2.8483. MEI Pharma and Kyowa Kirin Co announced data from the pivotal Phase 2 TIDAL studyof zandelisib as a single agent for follicular lymphoma (FL) patients who received at least two prior systemic therapies.
  • ERYTECH Pharma S.A. ERYP rose 15.4% to $2.75 after the company secured US patent directed to sequential use of methioninase & asparaginase against solid tumors.
  • Seres Therapeutics, Inc. MCRB surged 14% to $10.07. Seres Therapeutics said first patient was enrolled in Phase 1b study of SER-155 investigational microbiome therapeutic to reduce the risk of antibiotic-resistant bacterial infections and graft-versus-host disease.
  • Bakkt Holdings, Inc. BKKT gained 13% to $17.32.
  • Clarus Therapeutics Holdings, Inc. CRXT jumped 12.8% to $5.88 after the company announced issuance of two new patents for JATENZO.
  • Genetron Holdings Limited GTH surged 10.7% to $10.63 following Q3 results. Genetron Health announced Late monday, a co-development agreement with AstraZeneca R&D China for personalized MRD tests for solid tumors in China.
  • Chimerix, Inc. CMRX gained 8% to $6.33.
  • BeyondSpring Inc. BYSI rose 7.6% to $14.00 after tumbling over 9% on Monday.
  • Adagene Inc. ADAG rose 7.2% to $9.11 after the company reported the FDA clearance of IND for Phase 1b/2 trial of anti-CTLA-4 monoclonal antibody ADG116 in combination therapy with anti-PD-1 antibody pembrolizumab.

Check out these big penny stock gainers and losers


  • AeroClean Technologies, Inc. AERC fell 56.2% to $51.39 after jumping around 45% on Monday.
  • Olema Pharmaceuticals, Inc. OLMA shares dipped 56% to $9.64 after the company announced first clinical data from the Phase 1 dose-escalation portion of the ongoing Phase 1/2 clinical trial of OP-1250.
  • TG Therapeutics, Inc. TGTX fell 39.9% to $14.05 after the company reported the FDA plans to host a meeting of the Oncologic Drugs Advisory Committee in connection with its review of the pending BLA/sNDA for the combination of ublituximab and UKONIQ.
  • Palatin Technologies, Inc. PTN shares fell 21.6% to $0.6706 after gaining more than 50% on Monday.
  • Petros Pharmaceuticals, Inc. PTPI dipped 20% to $3.2001 after surging over 91% on Monday.
  • Barnes & Noble Education, Inc. BNED fell 19.7% to $7.14 after the company reported worse-than-expected Q2 EPS and sales results.
  • cbdMD, Inc. YCBD fell 18.8% to $1.5750. CbdMD shares jumped 30% on Monday after the company announced a multi-year exclusive agreement with Amify, an Amazon.com platform partner.
  • StoneX Group Inc. SNEX dropped 18.4% to $53.63 following Q4 results.
  • Biofrontera Inc. BFRI fell 15% to $6.03 following Q3 results.
  • NRx Pharmaceuticals, Inc. NRXP fell 14.6% to $6.92. NRx Pharmaceuticals rose 20% on Monday after the company announced positive data from its ZYESAMI study.
  • Baozun Inc. BZUN dipped 13.3% to $12.86 as the company reported third-quarter FY21 revenue growth of 3.8% year-on-year to $294.7 million (RMB1.9 billion), missing the consensus of $303.5 million.
  • RLX Technology Inc. RLX fell 13% to $4.41.
  • Longeveron Inc. LGVN dipped 11.8% to $23.15 after dropping 14% on Monday.
  • Pasithea Therapeutics Corp. KTTA fell 10.3% to $3.81.
  • Dillard's, Inc. DDS dipped 10% to $305.94.
  • Array Technologies, Inc. ARRY fell 9.8% to $20.61 after the company reported a proposed private offering of $325 million of convertible senior notes.
  • Micro Focus International plc MFGP fell 7.9% to $4.6042. Micro Focus, earlier during the month, announced it will sell its archiving and risk management portfolio to Smarsh.
  • Valneva SE VALN fell 6.2% to $63.13. Valneva shares climbed around 13% on Monday after the company and IDT Biologika announced a collaboration to produce Valneva's inactivated COVID-19 vaccine candidate VLA2001.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!